Public-domain · open source
OpenJurist

21 U.S.C. § 877

Section 877 · Judicial review

This is § 507 of the Controlled Substances Act

Amended 1 time on record

Applied in 93 court decisions — leading case PDK Laboratories Inc. v. United States Drug Enforcement Administration (2004)

Most recently applied in Advanced Integrative Medical Science Institute, Pllc v. United States Drug Enforcement Admin (February 2025)

How often courts cite this section

197019801990200020102020202510091-513enacted · 1970 · 91-513PDK Laboratories Inc. v. United States Drug Enforcement Administrationleading · 2004 · PDK Laboratories Inc. v. United States Drug Enforcement Administration
citing decisions per year

Court decisions citing this, by year.Markers show enactment, consequential amendments, and circuit splits over this section — watch for a citation surge after a change or a disagreement. The dip in the last several years is a data-coverage gap, not a real trend — our corpus holds fewer opinions from the most recent years, so recent citations are undercounted.

All final determinations, findings, and conclusions of the Attorney General under this subchapter shall be final and conclusive decisions of the matters involved, except that any person aggrieved by a final decision of the Attorney General may obtain review of the decision in the United States Court of Appeals for the District of Columbia or for the circuit in which his principal place of business is located upon petition filed with the court and delivered to the Attorney General within thirty days after notice of the decision. Findings of fact by the Attorney General, if supported by substantial evidence, shall be conclusive.

/21/usc/877 · .json · Public domain